| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.096 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.08 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |